UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:


Notice: Undefined offset: 0 in /var/www/html/gradynewsource/public_html/wordpress/wp-content/themes/onfleek/inc/df-core/views/df-content/df-post-layout-5.php on line 201

You May Also Like

New UGA Organization Works to Overcome Youth Obesity

With hotter and hotter temperatures and summer right around the corner, the urge to ...

Lottie Smalley’s Youtube ‘Side Hustle’ is Also a Career Move

Lottie Smalley, a junior public relations major at the University of Georgia, is a ...

University of Alabama Gives Opinion on Senate Bill 323

ATEHNS, Ga. — The recent Georgia Senate Bill 323 has caused concern for many ...

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close